Hepatoprotective effect of opioid peptides in stress

Introduction: Influence of the endogenous opioid system on the liver has not been studied enough. To understand the damaging effects of stress on the liver and the hepatoprotective effects of opioids, a study was performed on stress-resistant and stress-susceptible animals. Materi...

Full description

Bibliographic Details
Main Authors: Alexey V. Solin, Yury D. Lyashev, Nikolay V. Tsygan
Format: Article
Language:English
Published: Belgorod National Research University 2019-03-01
Series:Research Results in Pharmacology
Online Access:https://rrpharmacology.pensoft.net/article/34472/download/pdf/
_version_ 1827616865410613248
author Alexey V. Solin
Yury D. Lyashev
Nikolay V. Tsygan
author_facet Alexey V. Solin
Yury D. Lyashev
Nikolay V. Tsygan
author_sort Alexey V. Solin
collection DOAJ
description Introduction: Influence of the endogenous opioid system on the liver has not been studied enough. To understand the damaging effects of stress on the liver and the hepatoprotective effects of opioids, a study was performed on stress-resistant and stress-susceptible animals. Materials and methods: The investigation was performed on 725 Wistar male-rats. Various types of stress were modeled: acute immobilization stress of various duration (3, 6 and 12 hours), chronic stress of limited mobility, swimming stress and traumatic stress (resection of 70% of the liver). Agonists of various types of opioid receptors in equimolar doses were injected to stressed animals at equimolar doses: DAGO – a mu-receptor agonist – at a dose of 6.3 mcg/kg, DSLET – a delta-receptor agonist – at a dose of 10 mcg/kg, and kappa receptor agonist dynorphin A (1-13) – at a dose of 20.1 mcg/kg. Results and discussion: The stress-limiting action of the studied opioids is characterized by the reduced hepatocyte dystrophy, microcirculation correction, a decreased concentration of lipid peroxidation metabolites, a suppressed cytolytic syndrome, a stimulated synthetic ability of the liver, and is more pronounced in stress- susceptible animals. The greatest stress-protective effect is shown after administering dynorphin A (1-13) in immobilization stress, and DAGO – in swimming stress. Dynorphin A (1-13) and DAGO manifested the most pronounced effect on the liver regeneration after resection. A preliminary stress simulation accelerates liver regeneration at the initial stage after resection. Conclusion: The hepatoprotective effect of opioids in stress depends on the typological peculiarities of animals. The results obtained offer a challenge of synthesizing new hepatoprotectors.
first_indexed 2024-03-09T09:33:55Z
format Article
id doaj.art-725219d76c8d471cbfb8d7bb57dab0c5
institution Directory Open Access Journal
issn 2658-381X
language English
last_indexed 2024-03-09T09:33:55Z
publishDate 2019-03-01
publisher Belgorod National Research University
record_format Article
series Research Results in Pharmacology
spelling doaj.art-725219d76c8d471cbfb8d7bb57dab0c52023-12-02T02:42:21ZengBelgorod National Research UniversityResearch Results in Pharmacology2658-381X2019-03-0151779610.3897/rrpharmacology.5.3447234472Hepatoprotective effect of opioid peptides in stressAlexey V. Solin0Yury D. Lyashev1Nikolay V. Tsygan2Kursk State Medical UniversityKursk State Medical UniversityB.P. Konstantinov Petersburg Nuclear Physics InstituteIntroduction: Influence of the endogenous opioid system on the liver has not been studied enough. To understand the damaging effects of stress on the liver and the hepatoprotective effects of opioids, a study was performed on stress-resistant and stress-susceptible animals. Materials and methods: The investigation was performed on 725 Wistar male-rats. Various types of stress were modeled: acute immobilization stress of various duration (3, 6 and 12 hours), chronic stress of limited mobility, swimming stress and traumatic stress (resection of 70% of the liver). Agonists of various types of opioid receptors in equimolar doses were injected to stressed animals at equimolar doses: DAGO – a mu-receptor agonist – at a dose of 6.3 mcg/kg, DSLET – a delta-receptor agonist – at a dose of 10 mcg/kg, and kappa receptor agonist dynorphin A (1-13) – at a dose of 20.1 mcg/kg. Results and discussion: The stress-limiting action of the studied opioids is characterized by the reduced hepatocyte dystrophy, microcirculation correction, a decreased concentration of lipid peroxidation metabolites, a suppressed cytolytic syndrome, a stimulated synthetic ability of the liver, and is more pronounced in stress- susceptible animals. The greatest stress-protective effect is shown after administering dynorphin A (1-13) in immobilization stress, and DAGO – in swimming stress. Dynorphin A (1-13) and DAGO manifested the most pronounced effect on the liver regeneration after resection. A preliminary stress simulation accelerates liver regeneration at the initial stage after resection. Conclusion: The hepatoprotective effect of opioids in stress depends on the typological peculiarities of animals. The results obtained offer a challenge of synthesizing new hepatoprotectors.https://rrpharmacology.pensoft.net/article/34472/download/pdf/
spellingShingle Alexey V. Solin
Yury D. Lyashev
Nikolay V. Tsygan
Hepatoprotective effect of opioid peptides in stress
Research Results in Pharmacology
title Hepatoprotective effect of opioid peptides in stress
title_full Hepatoprotective effect of opioid peptides in stress
title_fullStr Hepatoprotective effect of opioid peptides in stress
title_full_unstemmed Hepatoprotective effect of opioid peptides in stress
title_short Hepatoprotective effect of opioid peptides in stress
title_sort hepatoprotective effect of opioid peptides in stress
url https://rrpharmacology.pensoft.net/article/34472/download/pdf/
work_keys_str_mv AT alexeyvsolin hepatoprotectiveeffectofopioidpeptidesinstress
AT yurydlyashev hepatoprotectiveeffectofopioidpeptidesinstress
AT nikolayvtsygan hepatoprotectiveeffectofopioidpeptidesinstress